Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by G. A. Salles
Single Nucleotide Polymorphisms in ABCB1 and CBR1 Can Predict Toxicity to R-Chop Type Regimens in Patients With Diffuse Non-Hodgkin Lymphoma
Haematologica
Hematology
Related publications
3A Comparison Between R-THP-Cop and R-Chop Regimens for the Treatment of Diffuse Large B-Cell Lymphoma in Old Patients: A Single-Institution Analysis
Internal Medicine
Internal Medicine
Medicine
Differences in Quality of Life Between Bendamustine-Rituximab and R-Chop/R-CVP in Patients With Previously Untreated Advanced Indolent Non-Hodgkin Lymphoma or Mantle Cell Lymphoma
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Gene Mutations and Copy Number Alterations (Cna) Predict for Early Failure in Patients With Diffuse Large B-Cell Lymphoma (Dlbcl) Treated With R-Chop
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
CD30 Expression in Diffuse Large B-Cell Lymphoma Correlates With Non-GCB Subtype but Does Not Have Prognostic Impact in Patients Treated With First Line R-Chop/R-Chop-Like
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Blood Lymphocyte-To-Monocyte Ratio Identifies High-Risk Patients in Diffuse Large B-Cell Lymphoma Treated With R-Chop
PLoS ONE
Multidisciplinary
Multiplex Polymerase Chain Reaction-Based Prognostic Models in Diffuse Large B-Cell Lymphoma Patients Treated With R-Chop
British Journal of Haematology
Hematology
Population-Based Study on Different Regimens of R-Chop in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma in the Netherlands Supports the Use of 6 Cycles of R-Chop21
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
ROBUST: First Report of Phase III Randomized Study of Lenalidomide/R-Chop (R2 -CHOP) vs Placebo/R-Chop in Previously Untreated ABC-type Diffuse Large B-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
R-Chop With or Without Bevacizumab in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma: Final MAIN Study Outcomes
Haematologica
Hematology
